NEW TARGET FOR INHIBITORS AGAINST EBOLA VIRUS

摘要

Ebola virus causes outbreaks of rapidly fatal hemorrhagic fever in central Africa. Because there is no effective vaccine or antiviral therapy, there is a high level of public concern about the transmission of Ebola virus. Moreover, the massive production of proinflammatory cytokines in response to infection causes capillary leak and hypovolemic shock.